From the Chairman: Paolo Casali, M.D.

The Department of Microbiology, Immunology & Molecular Genetics is part of the Long School of Medicine at the University of Texas Health Science Center at San Antonio. Our faculty conducts research on the immune system, infectious agents and cancer. Accordingly, the department is the nucleus for research and education in immunological and microbiological topics for the five schools at the University of Texas Health Science Center at San Antonio, and provides a dynamic environment for scientific discovery and training.

Our mission is to further research in molecular immunology, microbial pathogenesis, tumor immunology, autoimmunity, immunodeficiencies and development of the immune system, in order to build the knowledge necessary for vaccines and therapies of the future.  We use molecular genetics and epigenetics approaches in conjunction with next-generation sequencing tools to dissect mechanisms for generations of antibodies and lymphocytes that protect against viruses, bacteria, fungi, as well as tumor cells.  We also strive to understand molecular mechanisms of tumorigenesis, with particular emphasis on B lymphocyte neoplastic transformation in the context of the developing immune system. To this end, basic and translational research are of equal importance, to foster discovery of biological truths and translate those discoveries into new therapeutics.

We are committed to developing the next generation of scientists in biomedical research with an emphasis on molecular immunology, and to this end, we offer a spectrum of training opportunities. We house an Undergraduate Research Program, in addition to a Master of Science Program in Immunology and Infection. Our faculty also teach and mentor PhD students through the Infection, Inflammation and Immunity Discipline of the Integrated Biomedical Science Program in the Graduate School of Biomedical Sciences, in addition to providing the teaching in immunology and infection to our medical students. Finally, in addition to undergraduate and graduate trainees, Postdoctoral Fellows are important in our overall research effort. Postdoctoral fellowships are available in most laboratories of the Department of Microbiology, Immunology & Molecular Genetics.


Learning and Training Opportunities

The Department of Microbiology, Immunology & Molecular Genetics supports a variety of learning and training opportunities in seminars, lectures and events, including

Contact the Program Coordinators at:

Upcoming Deadlines

  • Cancer Prevention and Research Institute of Texas [CPRIT] (RFA R-18.2-HIHR) – January 31, 2018 (4:00 p.m. Central)
  • NIH R01 (New) – February 5, 2018
  • NIH R21 (New) – February 16, 2018
  • Voelcker Fund Young Investigator Award – February 23, 2018

NIAID Funding Opportunities: Click Here
NCI Funding Opportunities: Click Here
NIGMS Funding Opportunities: Click Here
NIA Funding Opportunities: Click Here
Office of Sponsored Programs (OSP): Click Here

Additional Funding Opportunities:

Xiangya Medical Student Research Program

The Xiangya Medical Student Research Program is an opportunity for faculty to recruit and mentor medical students from the Xiangya School of Medicine (Changsha, China).

Students from the Xiangya Medical School are given the opportunity to spend two years away from their home institute of Xiangya to gain hands on research experience in a lab at the UT Health Science Center San Antonio.

MIMG Faculty member, Dr. Guangming Zhong, founded the program in which we now have nearly 30 students from Xiangya working in UT Health SA labs, many of which work in MIMG labs.

Dr. Zhong is currently flanked by Dr. Casali who has been a strong supporter of the program since it’s inception.

Not only is this a wonderful experience for the medical students, but also for our faculty, staff and students who are able to learn about a new culture and expand their collaborative network.

New Grant Awards

  • Dr. Evelien Bunnik was recently awarded NIH R21 grant “Structure and function of protective antibodies from memory B cells against malaria”
  • Dr. Evelien Bunnik was recently awarded NIH R21 grant “Discovery of antibodies against the blood stage of the malaria parasite”
  • Dr. Alexei Tumanov was recently awarded The Peter Bradley Carlson Trust grant “Overcoming roadblocks of anti-CD137 cancer therapy”
  • Dr. Elizabeth Leadbetter was recently awarded NIH R01 grant “Innate modulation of autoimmune, regulatory, and effector B cells in adipose tissue”
  • Dr. Zhenming Xu was recently awarded DOD grant “Role of B cells and IL-27 in breast cancer progression and drug resistance”
  • Dr. Brian Wickes was recently awarded NIH R21 grant “Antifungal Resistance Gene Targeting in Candida glabrata by Target Capture”
  • Dr. Alexei Tumanov was recently awarded NIH R21 grant “Innate lymphoid cells in Campylobacteri-induced colitis”
  • Dr. Thomas Hägglöf, Postdoctoral Fellow in Dr. Elizabeth Leadbetter’s lab was recently awarded International Postdoc grant from the Swedish Research Council administered by the Karolinska Institutet in Sweden.